Pfizer CEO says he’s prepared to shift manufacturing to the U.S. amid tariff threats

Pfizer (PFE) CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if necessary, as the Trump administration considers imposing tariffs on pharmaceuticals.